Aesica, the U.K.-based contract manufacturer, has a new plant going online but one with a very specialized purpose.
The way execs at Piramal Healthcare see it, there are good reasons to expand production at Piramal's hormonal medicines plant in Morpeth, U.K. The market is worth $11 billion and growing at 4% to 5% a year, and there are not many contract manufacturers that play in that space. And so the Indian manufacturer will triple production there.
International Chemical Investors Group (ICIG) has nabbed another operation to fold into its contract manufacturing arm Corden Pharma group: Peptisyntha, a Brussels, Belgium-based custom manufacturer of peptides for pharmaceuticals. It will become its third site offering this service.
Irish drugmaker Amarin continues to stack up manufacturing partners for the API for its fish oil drug Vascepa. While its decision to launch the drug without a partner has meant slow going in getting it to market, Amarin has pushed ahead with deals with contract manufacturers, hoping to get FDA approval for a fourth API maker.
Jubilant HollisterStier, a Spokane, WA-based contract manufacturer, says it has completed the first phase of an expansion at a plant in Montreal. The company did not give specifics but said the project increases its capacity there by nearly 200% and will be ready for products early next month.
Accellent sprouted healthy revenue growth in its 2013 second quarter, but reorganization costs helped push net losses higher for the medical device contract manufacturer.
Vivus signed a partnership deal in June with Italy's Menarini to help it roll out its erectile dysfunction drug Stendra (Spedra in the EU).
Besides making drugs for other companies and selling over-the-counter products in India, contract manufacturer Piramal Enterprises does its own drug development and owns a big stake in India's cellphone market as well as a piece of a transport lender.
At a time when the FDA is urging drugmakers to work more closely with contractors on quality, Roche says it is already doing it.
Contract manufacturer Catalent Pharma Solutions is expanding again, this time at a controlled release drug manufacturing facility in Winchester, KY, with a little help from that state.